Genmab — December 2021

[Bulder]

They probably have more faith in hex38 regarding MM.

[E_L]

hex38 seems to be all about safety. genmab have enough cd38 knowledge to know if hex38 is potent enough to beat Dara i would think

[E_L]

every day that goes by without a 'Hold' on that trial is a + lol

[E_L]

i imagine they move this very very slowly to prevent that from happening... which is also why i am not so sure we should expect too much info at the R&D day

[E_L]

it is why i asked Jan how many patients had been dosed yet at Q&A, but he didn't answer

[E_L]

on the other hand, you could probably not have a better starting point for this drug then Vejle hospital with Plesner ; if anyone would know how to move this forward it is probably him

[Bulder]

They haven

[Bulder]

t updated on this study since Sept 2. So accoeding to that it is still only Vejle and Karolinska recruiting.

[E_L]

we saw with the epco R/R CLL trial only 7 patients were enrolled in about 7/8 months; i wouldn't be surprised if this is going with the same speed

[E_L]

'speed'
not being the best choice of words here

[E_L]

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-darzalex-faspro-kyprolis-and-dexamethasone-multiple-myeloma

[E_L]

Dara Kyprolis combi
approved

[Bulder]

Nice

[Legolas23]

Thumps up

[Sukkeralf]

Just a moment...

(firstwordpharma.com)

[Legolas23]

Kan du sætte lidt prosa. Linket kræver medlemskab.

[Bulder]

Hvad handler det om sukkeralf?

[Helge_LarsenPI-redaktør]

God morgen.

[GeorgeBest]

Denne onkolog undrer sig over hvorfor man overhovedet vil anvende CAR-T i MM, når man snart kan få Teclistamab som vil være „safer, better, easier and cheaper“ https://twitter.com/drpaulydesantis/status/1466262720127258625?s=21

[Sukkeralf]

Detailed results from Roche's POLARIX study are poised to be one of the highlights at next week's annual meeting of the American Society of Hematology (ASH).